NCT03679884: A reported trial by Idorsia Pharmaceuticals Ltd.
This trial has reported on time, in line with the regulations.
Full data
Full entry on ClinicalTrials.gov | NCT03679884 |
---|---|
Title | Multi-center, Double-blind, Parallel-group, Randomized, Placebo-controlled, Three Doses, 40-week Extension to Studies ID-078A301 and ID-078A302 to Assess the Long Term Safety and Tolerability of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder |
Results Status | Reported |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | Oct. 9, 2018 |
Completion date | Feb. 22, 2021 |
Required reporting date | Feb. 22, 2022, midnight |
Actual reporting date | Jan. 7, 2022 |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |